Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Anzu Special Acquisition Corp I (ANZU) Competitors

Anzu Special Acquisition Corp I logo

ANZU vs. MLSS, APT, RBOT, SPAI, COCH, CLGN, LFWD, POAI, HSCS, and BBLG

Should you be buying Anzu Special Acquisition Corp I stock or one of its competitors? The main competitors of Anzu Special Acquisition Corp I include Milestone Scientific (MLSS), Alpha Pro Tech (APT), Vicarious Surgical (RBOT), Safe Pro Group Inc. Common Stock (SPAI), Envoy Medical (COCH), CollPlant Biotechnologies (CLGN), ReWalk Robotics (LFWD), Predictive Oncology (POAI), Heart Test Laboratories (HSCS), and Bone Biologics (BBLG). These companies are all part of the "surgical appliances & supplies" industry.

Anzu Special Acquisition Corp I vs. Its Competitors

Milestone Scientific (NYSE:MLSS) and Anzu Special Acquisition Corp I (NASDAQ:ANZU) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, valuation, risk, dividends, earnings, analyst recommendations, institutional ownership, community ranking and media sentiment.

Milestone Scientific received 2 more outperform votes than Anzu Special Acquisition Corp I when rated by MarketBeat users.

CompanyUnderperformOutperform
Milestone ScientificOutperform Votes
2
2.17%
Underperform Votes
90
97.83%
Anzu Special Acquisition Corp IN/AN/A

Anzu Special Acquisition Corp I has lower revenue, but higher earnings than Milestone Scientific.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Milestone Scientific$8.61M8.02-$6.93M-$0.07-12.57
Anzu Special Acquisition Corp IN/AN/A$19.23MN/AN/A

Anzu Special Acquisition Corp I has a net margin of 0.00% compared to Milestone Scientific's net margin of -52.01%. Anzu Special Acquisition Corp I's return on equity of -17.33% beat Milestone Scientific's return on equity.

Company Net Margins Return on Equity Return on Assets
Milestone Scientific-52.01% -60.26% -40.23%
Anzu Special Acquisition Corp I N/A -17.33%1.37%

5.8% of Milestone Scientific shares are owned by institutional investors. Comparatively, 27.3% of Anzu Special Acquisition Corp I shares are owned by institutional investors. 24.8% of Milestone Scientific shares are owned by company insiders. Comparatively, 0.7% of Anzu Special Acquisition Corp I shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Milestone Scientific has a beta of 0.9, meaning that its share price is 10% less volatile than the S&P 500. Comparatively, Anzu Special Acquisition Corp I has a beta of 0.03, meaning that its share price is 97% less volatile than the S&P 500.

Milestone Scientific currently has a consensus price target of $1.25, indicating a potential upside of 42.05%. Given Milestone Scientific's stronger consensus rating and higher possible upside, equities research analysts clearly believe Milestone Scientific is more favorable than Anzu Special Acquisition Corp I.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Milestone Scientific
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Anzu Special Acquisition Corp I
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

In the previous week, Milestone Scientific had 6 more articles in the media than Anzu Special Acquisition Corp I. MarketBeat recorded 6 mentions for Milestone Scientific and 0 mentions for Anzu Special Acquisition Corp I. Anzu Special Acquisition Corp I's average media sentiment score of 0.44 beat Milestone Scientific's score of -0.04 indicating that Anzu Special Acquisition Corp I is being referred to more favorably in the news media.

Company Overall Sentiment
Milestone Scientific Neutral
Anzu Special Acquisition Corp I Neutral

Summary

Milestone Scientific beats Anzu Special Acquisition Corp I on 8 of the 14 factors compared between the two stocks.

Get Anzu Special Acquisition Corp I News Delivered to You Automatically

Sign up to receive the latest news and ratings for ANZU and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ANZU and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ANZU vs. The Competition

MetricAnzu Special Acquisition Corp ISurgical appliances & supplies IndustryMedical SectorNASDAQ Exchange
Market Cap$20.47M$9.17B$5.57B$8.50B
Dividend YieldN/A1.26%5.28%4.16%
P/E RatioN/A20.5926.6319.64
Price / SalesN/A44.56407.99152.17
Price / Cash3.7419.6738.2534.64
Price / Book-0.815.096.964.60
Net Income$19.23M$284.66M$3.23B$248.06M

Anzu Special Acquisition Corp I Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ANZU
Anzu Special Acquisition Corp I
N/A$1.37
-4.9%
N/A-42.9%$20.47MN/A0.003
MLSS
Milestone Scientific
2.2655 of 5 stars
$0.91
+0.8%
$1.25
+37.0%
+24.9%$71.61M$8.61M-13.0330Short Interest ↑
High Trading Volume
APT
Alpha Pro Tech
0.9575 of 5 stars
$4.56
-1.5%
N/A-9.5%$49.54M$58.18M12.32120
RBOT
Vicarious Surgical
1.1209 of 5 stars
$7.65
+0.0%
$9.25
+20.9%
-20.6%$45.38MN/A-0.743Gap Down
SPAI
Safe Pro Group Inc. Common Stock
N/A$2.77
+3.7%
N/AN/A$42.03M$2.05M-3.4211News Coverage
COCH
Envoy Medical
2.2505 of 5 stars
$1.53
+9.7%
$9.25
+506.6%
-49.1%$32.52M$212K-1.1134Positive News
Short Interest ↑
CLGN
CollPlant Biotechnologies
2.7184 of 5 stars
$1.94
-5.4%
$11.50
+492.8%
-71.6%$22.22M$2.47M-1.2670High Trading Volume
LFWD
ReWalk Robotics
2.5169 of 5 stars
$1.21
+1.7%
$9.00
+643.8%
-75.8%$13.32M$25.41M-0.4960Short Interest ↑
Gap Up
POAI
Predictive Oncology
1.9689 of 5 stars
$0.94
-1.2%
$3.00
+219.6%
-23.8%$8.38M$1.73M-0.3130News Coverage
Short Interest ↑
HSCS
Heart Test Laboratories
2.6549 of 5 stars
$3.58
-0.3%
$13.00
+263.1%
-32.8%$3.87M$14.70K-0.4510Short Interest ↑
Gap Down
BBLG
Bone Biologics
1.442 of 5 stars
$0.80
-0.8%
N/A-49.4%$2.62MN/A0.002Stock Split
Short Interest ↓
Analyst Revision
Gap Down

Related Companies and Tools


This page (NASDAQ:ANZU) was last updated on 6/14/2025 by MarketBeat.com Staff
From Our Partners